Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Key Record Dates Identifier: NCT02416388
Brief Title: Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR (BIG-1)

First Submitted : April 7, 2015
First Submitted that Met QC Criteria : April 9, 2015
First Posted : April 15, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : April 12, 2017
Last Update Posted : April 14, 2017